ISSN |
1007-9327 (print) and 2219-2840 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Retrospective Study |
Article Title |
Transjugular intrahepatic portosystemic shunt for pyrrolizidine alkaloid-related hepatic sinusoidal obstruction syndrome
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Chun-Ze Zhou, Rui-Feng Wang, Wei-Fu lv, Yu-Qin Fu, De-Lei Cheng, Yi-Jiang Zhu, Chang-Long Hou and Xian-Jun Ye |
ORCID |
|
Funding Agency and Grant Number |
Funding Agency |
Grant Number |
China Hepatitis Prevention and Treatment Foundation Scientific Research Subject |
TQGB20180247 |
Anhui Province Natural Science Foundation Projects |
1808085MH254 |
|
Corresponding Author |
Wei-Fu lv, MD, Doctor, Doctor, Interventional Radiology Department, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, No, 17, Lujiang Road, Hefei 230001, Anhui Province, China. weifulv@ustc.edu.cn |
Key Words |
Transjugular intrahepatic portosystemic shunt; Sinusoidal obstruction syndrome; Pyrrolizidine alkaloids; Survival; Ascites; |
Core Tip |
Kaplan-Meier analysis revealed significantly longer survival for the transjugular intrahepatic portosystemic shunting (TIPS) group than for the conservative treatment group in this retrospective study. Compared with the pre-treatment value, maximal ascites depth was significantly lower at 1 wk, 2 wk, 1 mo, and 3 mo for the TIPS group (all P < 0.05) but not the conservative treatment group. Contrast-enhanced computed tomography demonstrated the disappearance of patchy liver enhancement after TIPS. |
Publish Date |
2020-06-28 10:42 |
Citation |
Zhou CZ, Wang RF, Lv WF, Fu YQ, Cheng DL, Zhu YJ, Hou CL, Ye XJ. Transjugular intrahepatic portosystemic shunt for pyrrolizidine alkaloid-related hepatic sinusoidal obstruction syndrome. World J Gastroenterol 2020; 26(24): 3472-3483 |
URL |
https://www.wjgnet.com/1007-9327/full/v26/i24/3472.htm |
DOI |
https://dx.doi.org/10.3748/wjg.v26.i24.3472 |